Sec. 3a.
(1) Effective February 17, 1998, the Michigan biologic products institute, established by Executive Order 1995-25, is transferred to the Michigan department of community health as a type I transfer. As used in this subsection, "type I transfer" means that term as defined in section 3 of the executive organization act of 1965, 1965 PA 380, MCL 16.103.
(2) The institute is an independent and autonomous entity. The institute and the director of the institute shall exercise the powers and perform the duties prescribed by this act independently of the principal executive departments of this state, including, but not limited to, personnel, budgeting, procurement, and management-related functions.
(3) The governor shall appoint a director for the institute, who shall be the head of the institute, within the meaning of the executive organization act of 1965, 1965 PA 380, MCL 16.101 to 16.608. The director is also the appointing authority for purposes of section 5 of article XI of the state constitution of 1963.
(4) The institute has the powers, duties, and responsibilities prescribed in Executive Order 1995-25, and shall operate pursuant to and in accordance with Executive Order 1995-25.
History: Add. 1998, Act 8, Imd. Eff. Feb. 17, 1998
Structure Michigan Compiled Laws
Act 522 of 1996 - The Michigan Biologic Products Institute Transfer Act (333.26331 - 333.26340)
Section 333.26331 - Short Title.
Section 333.26332 - Legislative Findings and Declarations.
Section 333.26333 - Definitions.
Section 333.26334 - Michigan Biologic Products Commission; Conveyance of Assets; Powers and Rights.
Section 333.26335 - State Administrative Board; Powers and Duties.
Section 333.26336b - Total State Spending; Spending to Local Units of Government.
Section 333.26336c - Contingency Funds.
Section 333.26338 - Conveyance of Assets; Liens, Claims, or Interests.